A TLR6 polymorphism is associated with increased risk of Legionnaires' disease

Genes and Immunity

Volumn 14, Issue 7, 2013, Pages 420-426

  Misch, E A ^a   Verbon, A ^b   Prins, J M ^c   Skerrett, S J ^a   Hawn, T R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Legionella pneumophila; Legionnaires' disease; polymorphism; TLR6

Indexed keywords

TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6;

ADULT; ARTICLE; CELL STRAIN HEK293; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HOSPITAL INFECTION; HUMAN; HUMAN CELL; INFECTION RISK; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MAJOR CLINICAL STUDY; NETHERLANDS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TLR1 GENE; TLR2 GENE; TLR6 GENE;

LEGIONELLA PNEUMOPHILA;

ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEK293 CELLS; HUMANS; LEGIONNAIRES' DISEASE; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6;

EID: 84886726374     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.34     Document Type: Article

References (47)

1. Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990; 69: 307-316.
2. Jespersen S, Søgaard OS, Schønheyder HC, Fine MJ, Østergaard L. Clinical features and predictors of mortality in admitted patients with community- and hospital-acquired legionellosis: A Danish historical cohort study. BMC Infect Dis 2010; 10: 124.
3. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: Implications for management guidelines. Thorax 2001; 56: 296-301.
4. Neil K, Berkelman R. Increasing incidence of legionellosis in the United States, 1990-2005: Changing epidemiologic trends. Clin Infect Dis 2008; 47: 591-599.
5. Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J et al. Etiology of community-acquired pneumonia: Impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999; 160: 397-405.
6. Sabria M, Yu VL. Hospital-acquired legionellosis: Solutions for a preventable infection. Lancet Infect Dis 2002; 2: 368-373.
7. Hutchinson DN. Nosocomial legionellosis. Rev Med Micrbiol 1990; 1: 108-115.
8. Yu VL. Nosocomial legionellosis. Curr Opin Infect Dis 2000; 13: 385-388.
9. Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH, Wooten RM et al. Cutting edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J Immunol 1999; 163: 2382-2386.
10. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
11. Girard R, Pedron T, Uematsu S, Balloy V, Chignard M, Akira S et al. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J Cell Sci 2003; 116(Pt 2): 293-302.
12. Bulut Y, Faure E, Thomas L, Equils O, Arditi M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: Role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 2001; 167: 987-994.
13. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001; 13: 933-940.
14. Krutzik SR, Ochoa MT, Sieling PA, Uematsu S, Ng YW, Legaspi A et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med 2003; 9: 525-532.
15. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA et al. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 2001; 291: 1544-1547.
16. Akamine M, Higa F, Arakaki N, Kawakami K, Takeda K, Akira S et al. Differential roles of Toll-like receptors 2 and 4 in in vitro responses of macrophages to Legionella pneumophila. Infect Immun 2005; 73: 352-361.
17. Hawn TR, Smith KD, Aderem A, Skerrett SJ. Myeloid differentiation primary response gene (88)- and toll-like receptor 2-deficient mice are susceptible to infection with aerosolized Legionella pneumophila. J Infect Dis 2006; 193: 1693-1702.
18. Archer KA, Roy CR. MyD88-dependent responses involving toll-like receptor 2 are important for protection and clearance of Legionella pneumophila in a mouse model of Legionnaires' disease. Infect Immun 2006; 74: 3325-3333.
19. Fuse ET, Tateda K, Kikuchi Y, Matsumoto T, Gondaira F, Azuma A et al. Role of Tolllike receptor 2 in recognition of Legionella pneumophila in a murine pneumonia model. J Med Microbiol 2007; 56(Pt 3): 305-312.
20. Misch EA, Hawn TR. Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci (Lond) 2008; 114: 347-360.
21. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E et al. Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 2007; 178: 7520-7524.
22. Thuong NTT, Hawn TR, Thwaites GE, Chau TTH, Lan NTN, Quy HT et al. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun 2007; 8: 422-428.
23. Hawn TR, Verbon A, Janer M, Zhao LP, Beutler B, Aderem A. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. Proc Natl Acad Sci USA 2005; 102: 2487-2489.
24. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease. J Exp Med 2003; 198: 1563-1572.
25. Hawn TR, Scholes D, Li SS, Wang H, Yang Y, Roberts PL et al. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One 2009; 4: E5990.
26. Hawn TR, Misch EA, Dunstan SJ, Thwaites GE, Lan NT, Quy HT et al. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 2007; 37: 2280-2289.
27. Misch EA, Macdonald M, Ranjit C, Sapkota BR, Wells RD, Siddiqui MR et al. Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl Trop Dis 2008; 2: E231.
28. Boshuizen HC, Neppelenbroek SE, van Vliet H, Schellekens JFP, JWd Boer, Peeters MF et al. Subclinical Legionella infection in workers near the source of a large outbreak of Legionnaires disease. J Infect Dis 2001; 184: 515-518.
29. Chidiac C, Che D, Pires-Cronenberger S, Jarraud S, Campèse C, Bissery A et al. Factors associated with hospital mortality in community-acquired legionellosis in France. Eur Respir J 2012; 39: 963-970.
30. Campèse C, Bitar D, Jarraud S, Maine C, Forey Fo, Etienne J et al. Progress in the surveillance and control of Legionella infection in France, 1998-ì2008. Int J Infect Dis 2011; 15: E30-e37.
31. Den Boer JW, Yzerman PF, Schellekens J, Lettinga KD, Boshuizen HC, Van Steenbergen JE et al. A large outbreak of Legionnaires' disease at a flower show, the Netherlands, 1999. Emerg Infect Dis 2002; 8: 37-43.
32. Jespersen S, Søgaard OS, Fine MJ, Østergaard L. The relationship between diagnostic tests and case characteristics in Legionnaires' disease. Scand J Infect Dis 2009; 41: 425-432.
33. Sopena N, Force L, Pedro-Botet ML, Barrufet P, Sauca G, García-Núñez M et al. Sporadic and epidemic community legionellosis: Two faces of the same illness. Eur Respir J 2007; 29: 138-142.
34. Scharf S, Hippenstiel S, Flieger A, Suttorp N, N'Guessan PD. Induction of human beta-defensin-2 in pulmonary epithelial cells by Legionella pneumophila: Involvement of TLR2 and TLR5, p38 MAPK, JNK, NF-kB, and AP-1. Am J Physiol Lung Cell Mol Physiol 2010; 298: L687-L695.
35. Vance R, Hawn TR. The genetics and immunology of host resistance to Legionella infection. In: Heuner K, Swanson M (eds) Legionella: Molecular Microbiology. Caister Academic Press: Ann Arbor, MI, USA, 2008.
36. Braedel-Ruoff S, Faigle M, Hilf N, Neumeister B, Schild H. Legionella pneumophila mediated activation of dendritic cells involves CD14 and TLR2. J Endotoxin Res 2005; 11: 89-96.
37. Shim HK, Kim JY, Kim MJ, Sim HS, Park DW, Sohn JW. Legionella lipoprotein activates toll-like receptor 2 and induces cytokine production and expression of costimulatory molecules in peritoneal macrophages. Exp Mol Med 2009; 41: 687-694.
38. Ma X, Liu Y, Gowen BB, Graviss EA, Clark AG, Musser JM. Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One 2007; 2: E1318.
39. Kesh S, Mensah NY, Peterlongo P, Jaffe D, Hsu K, Van Den Brink M et al. TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann N Y Acad Sci 2005; 1062: 95-103.
40. Shey MS, Randhawa AK, Bowmaker M, Smith E, Scriba TJ, de Kock M et al. Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced interleukin-6 secretion. Genes Immun 2010; 11: 561-572.
41. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000; 97: 13766-13771.
42. Sanjuan MA, Dillon CP, Tait SWG, Moshiach S, Dorsey F, Connell S et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007; 450: 1253-1257.
43. Hajjar AM, O'Mahony DS, Ozinsky A, Underhill DM, Aderem A, Klebanoff SJ et al. Cutting edge: Functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 2001; 166: 15-19.
44. West TE, Ernst RK, Jansson-Hutson MJ, Skerrett SJ. Activation of Toll-like receptors by Burkholderia pseudomallei. BMC Immunol 2008; 9: 46.
45. Lettinga KD, Verbon A, Weverling GJ, Schellekens JF, Den Boer JW, Yzerman EP et al. Legionnaires' disease at a Dutch flower show: Prognostic factors and impact of therapy. Emerg Infect Dis 2002; 8: 1448-1454.
46. Storm N, Darnhofer-Patel B, van den Boom D, Rodi CP. MALDI-TOF mass spectrometry-based SNP genotyping. Methods Mol Biol 2003; 212: 241-262.
47. Shephard N. GENASS: Stata Module to Perform Genetic Case-Control Association Tests. Boston College Department of Economics: Chestnut Hill, MA, USA, 2005.